drugset / Trial / NCT00683111
Prevention of Gastrointestinal Bleeding in Patients With Severe Ischemic Heart Disease
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Aspirin and clopidogrel +/- heparin or thrombolytic co-therapy is well established and effective treatment for unstable cardiac patients. However, the major complication was gastrointestinal bleeding (GIB) due to peptic ulcer. In the prevention of GIB, anti-ulcer drug either H2-receptor antagonist (H2RA) and proton pump inhibitor (PPI) were commonly prescribed. There has been no prospective controlled study to compare the efficacy of these two classes of anti-ulcer drugs.
Timeline
- Start
- 2008-07
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Esomeprazole | Small molecule | 20 mg | Oral |
| Comparator | Famotidine | Other / unclassified | 40 mg | Oral |